BCM
ROIV icon

Beryl Capital Management’s Roivant Sciences ROIV Stock Holding History

Beryl Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-250,000
Closed -$2.81M – 22
2023
Q4 		$2.81M Buy
+250,000
New +$2.44M 1.54% 11

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Beryl Capital Management's ROIV Position: Q1 2024 in Review

Beryl Capital Management sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 250,000 shares — an estimated $2.81M sold.

Beryl Capital Management first reported a position in ROIV in Q4 2023 and held it in 1 quarter. The position peaked at $2.81M in Q4 2023. 260 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Beryl Capital Management reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
  • Beryl Capital Management sold 250,000 Roivant Sciences shares in Q1 2024, an estimated $2.81M.
  • Beryl Capital Management first reported a position in Roivant Sciences in Q4 2023 and held it in 1 quarter.
  • Beryl Capital Management's Roivant Sciences position peaked at $2.81M in Q4 2023.
  • 260 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Beryl Capital Management's 13F filing for Q1 2024, filed 15 May 2024.